Reclassification of sumatriptan

摘要

Most pharmacists are confident to sell sumatriptan over the counter but few have the opportunity, according to a study of pharmacists' early experiences of selling the drug after its switch from prescription-only status. Melanie Tasker, a preregistration trainee, presented the results of a study she conducted as part of her MPharm final-year project at the University of Nottingham. Semi-structured interviews were carried out with 20 community pharmacists in January and February 2007, around six months after sumatriptan became available over the counter.